The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma

被引:94
作者
Dahmani, Rajae [1 ]
Just, Pierre-Alexandre [1 ]
Perret, Christine [1 ]
机构
[1] Univ Paris 05, INSERM, U1016, Inst Cochin,CNRS,UMR 8104, F-75014 Paris, France
关键词
SMALL-MOLECULE ANTAGONISTS; BETA-CATENIN; IN-VIVO; GROWTH; CELLS; GENE; MUTATIONS; MOUSE; CANCER; LIVER;
D O I
10.1016/j.clinre.2011.05.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. However, targeted therapies are still at their beginning for the treatment of this poor-prognosis tumor. Among the signaling cascades deregulated in HCC, the Wnt/beta-catenin signaling pathway plays a key role in hepatic oncogenesis. Although it has been shown, using HCC cell lines, that inhibition of the beta-catenin signaling has anti-tumoral effect, no molecules targeting the Wnt pathway are currently tested in clinical trials for the treatment of HCC. Here we review our current knowledge about the role of the Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and the benefits and limits of targeting this pathway in HCC. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:709 / 713
页数:5
相关论文
共 31 条
[1]   Cholestasis is a marker for hepatocellular carcinomas displaying β-catenin mutations [J].
Audard, V. ;
Grimber, G. ;
Elie, C. ;
Radenen, B. ;
Audebourg, A. ;
Letourneur, F. ;
Soubrane, O. ;
Vacher-Lavenu, M-C ;
Perret, C. ;
Cavard, C. ;
Terris, B. .
JOURNAL OF PATHOLOGY, 2007, 212 (03) :345-352
[2]   Mining the Wnt pathway for cancer therapeutics [J].
Barker, Nick ;
Clevers, Hans .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :997-1014
[3]   Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma [J].
Bengochea, A. ;
de Souza, M. M. ;
Lefrancois, L. ;
Le Roux, E. ;
Galy, O. ;
Chemin, I. ;
Kim, M. ;
Wands, J. R. ;
Trepo, C. ;
Hainaut, P. ;
Scoazec, J-Y ;
Vitvitski, L. ;
Merle, P. .
BRITISH JOURNAL OF CANCER, 2008, 99 (01) :143-150
[4]   Apc tumor suppressor gene is the "zonation-keeper" of mouse liver [J].
Benhamouche, Samira ;
Decaens, Thomas ;
Godard, Cecile ;
Chambrey, Regine ;
Rickman, David S. ;
Moinard, Christophe ;
Vasseur-Cognet, Mireille ;
Kuo, Calvin J. ;
Kahn, Axel ;
Perret, Christine ;
Colnot, Sabine .
DEVELOPMENTAL CELL, 2006, 10 (06) :759-770
[5]   Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets [J].
Boyault, Sandrine ;
Rickman, David S. ;
de Reynies, Aurelien ;
Balabaud, Charles ;
Rebouissou, Sandra ;
Jeannot, Emmanuelle ;
Herault, Aurelie ;
Saric, Jean ;
Belghiti, Jacques ;
Franco, Dominique ;
Bioulac-Sage, Paulette ;
Laurent-Puig, Pierre ;
Zucman-Rossi, Jessica .
HEPATOLOGY, 2007, 45 (01) :42-52
[6]   Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer [J].
Chen, Baozhi ;
Dodge, Michael E. ;
Tang, Wei ;
Lu, Jianming ;
Ma, Zhiqiang ;
Fan, Chih-Wei ;
Wei, Shuguang ;
Hao, Wayne ;
Kilgore, Jessica ;
Williams, Noelle S. ;
Roth, Michael G. ;
Amatruda, James F. ;
Chen, Chuo ;
Lum, Lawrence .
NATURE CHEMICAL BIOLOGY, 2009, 5 (02) :100-107
[7]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[8]  
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
[9]   Stabilization of β-catenin affects mouse embryonic liver growth and hepatoblast fate [J].
Decaens, Thomas ;
Godard, Cecile ;
de Reynies, Aurelien ;
Rickman, David S. ;
Tronche, Francois ;
Couty, Jean-Pierre ;
Perret, Christine ;
Colnot, Sabine .
HEPATOLOGY, 2008, 47 (01) :247-258
[10]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576